-
Nippon India Pharma Fund - Growth
Equity healthcare
Overview ( as on 07/01/26 )
NAV
₹520.76
Last change
₹2.14 +0.0%
Fund Size (AUM)
8264.71 Cr
Performance
15.12% (5Y)
Fund Details
Nippon India Pharma Fund - Growth
as of 07/01/26
AUM
8264.71 Cr
Expense Ratio
1.81 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01968
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund - Growth | -1.7% | 22.78% | 15.12% |
| BSE Healthcare TR INR | -3.26% | 23.89% | 15.1% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.02% |
Lupin Ltd |
7.36% |
Divi's Laboratories Ltd |
6.58% |
Cipla Ltd |
6.39% |
Dr Reddy's Laboratories Ltd |
6.02% |
Apollo Hospitals Enterprise Ltd |
5.53% |
Vijaya Diagnostic Centre Ltd |
3.71% |
Medplus Health Services Ltd |
3.54% |
Ajanta Pharma Ltd |
3.21% |
Sai Life Sciences Ltd |
2.81% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
17.56% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
16.9% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
14.81% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
14.81% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
14.81% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
16.24% (5Y)
-
